Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma
Clinical trial NCT06179888 · SUSPENDED
Trial details
- NCT number
- NCT06179888
- Sponsor
- National Cancer Institute (NCI)
- Status
- SUSPENDED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-27
- Primary completion
- 2027-10-31
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.